Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Archives of Pathology & Laboratory Medicine|November 8, 2002
Laboratory evaluation of hypercoagulability with venous or arterial thrombosisElizabeth M Van Cott, Michael Laposata, Martin H Prins
Clinics in Laboratory Medicine|July 24, 2002
Hypercoagulability test strategies in the protein C and protein S pathwayElizabeth M Van Cott, Britt L Soderberg, Michael Laposata
Biochimica Et Biophysica Acta|December 6, 2005
Fatty acid ethyl esters, nonoxidative ethanol metabolites, synthesis, uptake, and hydrolysis by human plateletsRaneem O Salem, Joanne E Cluette-Brown, Michael Laposata
American Journal of Clinical Pathology|January 11, 2003
Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopeniaMajed A Refaai, Michael Laposata, Elizabeth M Van Cott
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 27, 2007
Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosisM Rabie Al-Turkmani, Steven D Freedman, Michael Laposata
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 31, 2005
Comparison of serum fatty acid ethyl esters and urinary 5-hydroxytryptophol as biochemical markers of recent ethanol consumptionAdam Bisaga, Michael Laposata, Shan Xie, et al.
Journal of Lipid Research|November 19, 2011
DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activitySarah W Njoroge, Michael Laposata, Waddah Katrangi, et al.
American Journal of Clinical Pathology|February 21, 2009
Evaluation of effectiveness of a computerized notification system for reporting critical valuesElisa Piva, Laura Sciacovelli, Martina Zaninotto, et al.
Biochimica Et Biophysica Acta|May 25, 2011
Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosisSarah W Njoroge, Adam C Seegmiller, Waddah Katrangi, et al.
The Journal of Nutritional Biochemistry|December 3, 2014
Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturasesSarah W Njoroge, Michael Laposata, Kelli L Boyd, et al.
Pageof 9